Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.39    
    

CERTAIN
MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. 

 
 

AMENDMENT NO. 3    
    
    TO THE DISTRIBUTION & INVENTORY MANAGEMENT    
    
    SERVICES AGREEMENT    

THIS
AMENDMENT NO. 3, dated as of December 1st, 2008 (the "Amendment"), by and between McKesson Corporation, a Delaware corporation with its principal place of business located at
One Post Street, San Francisco, CA 94104-5296 ("McKesson"), and Prometheus Laboratories Inc. ("Prometheus"), amends the Distribution & Inventory Management Services
Agreement, dated as of May 1st, 2004 and amended on December 10, 2004 and on November 6th, 2007 by and between McKesson and Prometheus, as follows
(unless otherwise defined herein, all capitalized terms shall have the same meaning ascribed to them in the Agreement): 

1.    Article 3.1
shall be stricken in its entirety and replaced with the following 

Term
and Termination. This Agreement shall remain in full force and effect until December 31st, 2010. Thereafter, this Agreement will automatically renew for subsequent one year
periods ("Renewal Term") unless terminated by either party as set forth below. This Agreement may be terminated by either party upon a material breach of the Agreement by the other party so long as
the terminating party has provided the other party with forty-five (45) days prior written notice of its intent to terminate and such material breach has not been cured during such
forty-five (45) day period. 

Non
Renewal. Either party may notify the other party of non-renewal of the Agreement upon advance written notice given not less than one hundred twenty (120) days prior to the
beginning of any Renewal Term. 

2.    Exhibit C
shall be stricken in its entirely and replaced with the following: 

 
 

Exhibit C    
    

[***].
Prometheus shall pay such fees no later than thirty (30) days after the end of each calendar quarter. All such fees will be paid to McKesson in the form of a
credit memo or check as determined by Prometheus. For purposes of this Agreement a "calendar quarter" shall mean the following consecutive three calendar month periods:
January 1—March 31, April 1—June 30, July 1—September 30 and October 1—December 31. McKesson
shall not be entitled to any fees or payments whatsoever except for those expressly set forth in this Agreement. 

[***].

Example:  

[****]

All
other Terms and Conditions of the Agreement, except as specifically amended herein, shall remain in full force and effect. 

IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first set forth above. 

	 

	Prometheus Laboratories Inc.	 	McKesson Corporation
	
By:	
 	

/s/  JOSEPH M. LIMBER      
	
 	

By:	
 	

/s/  MARK MILLER      

	

Date:	
 	

December 15, 2008
	
 	

Date:	
 	

December 11, 2008

	

Name:	
 	

Joseph M. Limber	
 	

Name:	
 	

Mark Miller
	Title:	 	President and Chief Executive Officer	 	Title:	 	VP of Investment Purchasing

***Certain
information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

QuickLinks

Exhibit 10.39

AMENDMENT NO. 3 TO THE DISTRIBUTION & INVENTORY MANAGEMENT SERVICES AGREEMENT

Exhibit CQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.40    
    

CERTAIN
MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION. 

 
 

AMENDMENT NO. 4    
    
    DISTRIBUTION & INVENTORY MANAGEMENT    
    
    SERVICES AGREEMENT    

This
AMENDMENT NO. 4 dated as of January 1, 2009 (the "Amendment"), by and between Cardinal Health* with its principal place of business located at 7000 Cardinal Place, Dublin, OH 43017
(Cardinal Health"), and Prometheus Laboratories Inc. ("Prometheus"), amends the Distribution & Inventory Management Services Agreement ("DSA"), dated as of June 1st,
2004 by and between Cardinal Health and Prometheus, as follows (unless otherwise defined herein, all capitalized terms shall have the meaning ascribed to them in the Agreement): 

1.    References to "Cardinal Health, Inc." and "Cardinal Health, Inc.*" in the DSA shall be stricken and replaced with
"Cardinal Health*". 

2.    The designation of "Borschow Hospital & Medical Supplies, Inc." to the DSA shall be ratified. 

3.    Article 1, section 1.1shall be stricken in its entirety and replaced with the following: 

1.1.    "Aggregate Inventory" means, at any given time, the total of Products in units that Cardinal Health has on hand at all of its storage
and/or distribution facilities and that Cardinal Health has on order (excluding all cross-dock then on order and drop-ship Product (Brokerage)). 

4.    Article 1, section 1.4 shall be stricken in its entirety and replaced with the following: 

1.4    "Average Weekly Movement" means, at any given time, the total quantity of Products in units, by National Drug Code (NDC) number, sold
by Cardinal Health to Customers less Cardinal Direct Returns over the immediately preceding [***] weeks divided by [***]. 

5.    Article 1, section 1.13 shall be stricken in its entirety and replaced with the following: 

1.13    "Cardinal
Direct Returns" means all Product returns that are sent back to Prometheus or its designee by Cardinal Health only. Such returns specifically exclude any morgue Product
returns, returns relating to new Product launches, and returns that originate from a Customer. 

6.    The first sentence in Article 3, Section 3.1 shall be stricken in its entirety and replaced with the following: 

"Term
and Termination. This Agreement shall remain in full force and effect through December 31, 2011 ("Initial Term")".

7.    Exhibit C shall be stricken in its entirety and replaced with the following: 

[***].
Prometheus shall pay such fees no later than thirty (30) days after the end of each Calendar Quarter. All such fees will be paid to Cardinal Health in the form of
a credit memo or check as determined by Prometheus. For purposes of this Agreement, a ("Calendar Quarter") shall mean the following calendar periods: January 1—March 31,
April 1—June 30, July 1—September 30, and October 1—December 31. Cardinal Health shall not be entitled to any fees or
payments whatsoever in consideration for the services hereunder except for those expressly set forth in this Agreement. 

[***]. 

Example:  

[***]

8.    This Amendment shall be effective on and after January 1, 2009 (the "Effective Date"). To the extent there are any
inconsistencies between the provisions of this Amendment and the provisions of the Agreement, the provisions of this Amendment will control but solely as to the subject matter herein. Capitalized
terms not otherwise defined herein shall have the same meaning given those terms in the Agreement, it being the intent of the parties that the Agreement and this Amendment will be applied and
construed as a single instrument. The Agreement, as modified by this Amendment and its exhibits, constitutes the entire agreement between Cardinal Health and Prometheus regarding the subject matter of
this Amendment and supersedes all prior or contemporaneous writings and understandings between the parties regarding the same. 

9.    This Amendment may by executed in counterparts, each of which, when executed and delivered, shall be deemed to be an original and all of
which together shall constitute one and the same document. Signatures to this Amendment transmitted by facsimile transmission, by electronic mail in "portable document format" (".pdf") form, or by any
other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as physical delivery of the paper document bearing the original
signature. 

Agreed
to and accepted by: 

	 

	 PROMETHEUS LABORATORIES INC.	 	CARDINAL HEALTH INC.
	

/s/  JOSEPH M. LIMBER      
	
 	

/s/  JEFFREY D. FOREMAN      

	Name:	 	Joseph M. Limber	 	Name:	 	Jeffrey D. Foreman
	Title:	 	President and Chief Executive Officer	 	Title:	 	VP Strategic Purchasing

	*
	"Cardinal
Health" means the following affiliated operating companies: Cardinal Health 3, LLC; Cardinal Health 104 LP; Cardinal Health 107, Inc.; Cardinal Health
110, Inc.; Cardinal Health 112, LLC; Cardinal Health 113, LLC; Cardinal Health 411, Inc.; Borschow Hospital & Medical Supplies, Inc.; and any other subsidiary
of Cardinal Health, Inc., an Ohio corporation ("CHI"), as may be designated by CHI.

	***
	Certain
information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the
omitted portions. 

QuickLinks

Exhibit 10.40

AMENDMENT NO. 4 DISTRIBUTION & INVENTORY MANAGEMENT SERVICES AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document
 

 
 

  Exhibit 10.2    
    

Stock Option No.             

 BRIDGEPOINT EDUCATION, INC.,

2005 STOCK INCENTIVE PLAN

NOTICE OF STOCK OPTION GRANT  

        You have been granted the following option to purchase common stock of Bridgepoint Education, Inc. (the "Company"): 

			
	Name of Optionee:	 	

 
	
Total Number of Shares Granted:	
 	

  ("Optioned Stock")
	
Type of Option:	
 	
o  Incentive Stock Option
	

 	
 	
o  Non-Statutory Stock Option
	
Exercise Price Per Share:	
 	
$

 
	
Date of Grant:	
 	

 
	
Date Exercisable:	
 	
This option may be exercised with respect to the first 25% of the Optioned Stock when the Optionee completes 12 months of continuous Service after the Vesting Commencement Date. This option may be exercised with
respect to an additional 2% of the Optioned Stock when the Optionee completes each of the next 33 consecutive months of continuous Service thereafter. This option may be exercised with respect to an additional 3% of the Optioned Stock when the
Optionee completes each of the 46th through 48th month of continuous Service after the Vesting Commencement Date.
	
Vesting Commencement Date:	
 	

 
	
Expiration Date:	
 	

 

1

 

By
your signature and the signature of the Company's representative below, you and the Company agree that this option is granted under and governed by the terms and conditions of this Notice of Stock
Option Grant, the Stock Option Agreement, and the Bridgepoint Education, Inc. 2005 Stock Incentive Plan, both of which are attached to and made a part of this document. 

					
	OPTIONEE	 	BRIDGEPOINT EDUCATION, INC.
	

 	
 	
By:	
 	
 

 
	

  Print Name	
 	
Title:	
 	

 
	

  Social Security Number	
 	

 	
 	

 

2

 

  BRIDGEPOINT EDUCATION, INC.

2005 STOCK INCENTIVE PLAN

STOCK OPTION AGREEMENT  

        1.    Definitions.    Unless otherwise defined herein, the terms defined in the Bridgepoint Education, Inc.
2005 Stock Incentive Plan (the "Plan") shall have the same defined meanings in this Stock Option Agreement. 

        2.    Grant of Option.    Pursuant to the terms and conditions set forth in the Notice of Stock Option Grant attached
hereto, this Agreement, and the Plan, Bridgepoint Education, Inc. (the "Company") grants to the optionee named in the Notice of Stock Option Grant ("Optionee") on the date of grant set forth in
the Notice of Stock Option Grant ("Date of Grant") the option to purchase, at the exercise price set forth in the Notice of Stock Option Grant ("Exercise Price"), the number of Shares set forth in the
Notice of Stock Option Grant. This option is intended to be an Incentive Stock Option or a Non-Statutory Stock Option, as provided in the Notice of Stock Option Grant. 

        3.    Exercise of Option.    Subject to the other conditions set forth in this Agreement, all or part of this option
may be exercised prior to its expiration at the time or times set forth in the Notice of Stock Option Grant; provided, however, the Optionee shall cease vesting in this option on the Optionee's
Termination Date. This option may also become exercisable in accordance with Section 21 below. Notwithstanding anything herein to the contrary, this option may not be exercised until the
stockholders of the Company have approved the Plan in accordance with Section 18 of the Plan. If the stockholders of the Company do not approve the Plan within the 12 months provided for
in Section 18 of the Plan, then this option shall terminate as of the end of such 12 month period. 

        4.    Expiration of Option.    Subject to the provisions of Section 5 hereof, this option shall expire and all
rights to purchase Shares hereunder shall cease on the date set forth in the Notice of Stock Option Grant ("Expiration Date"). 

        5.    Termination of Option.    In the event that the Optionee's Service terminates for any reason other than due to a
Disability, death, or Cause, this option shall expire on the date that is three months following the Optionee's Termination Date, unless this option would expire pursuant to Section 4 at an
earlier date in which case this option will expire on the earlier Expiration Date. In the event that the Optionee's Service terminates due to a Disability, this option shall expire on the date that is
12 months following the Optionee's Termination Date, unless this option would expire pursuant to Section 4 at an earlier date in which case this option will expire on the earlier
Expiration Date. In the event that the Optionee should die while in Service, this option shall expire on the date that is 12 months after the Optionee's death, unless this option would expire
pursuant to Section 4 at an earlier date in which case this option will expire on the earlier Expiration Date. In the event that the Optionee's Service terminates for Cause, this option shall
terminate on the Termination Date. 

        6.    Non-transferability of Option.    This option shall be non-transferable by the Optionee
other than by will or by the laws of descent and distribution, and shall be exercisable during the lifetime of the Optionee only by the Optionee, or as to Non-Statutory Stock Options also,
by the Optionee's guardian or legal representative. After the death of the Optionee, this option may be exercised prior to its termination by the Optionee's legal representative, heir or legatee, to
the extent permitted in the Plan. Upon any attempt to sell, transfer, assign, pledge, hypothecate or otherwise dispose of this option (a "Transfer"), or of any right or privilege conferred hereby,
contrary to the provisions hereof, or upon any attempted sale under any execution, attachment or similar process upon the rights and privileges conferred hereby, this option and the rights and
privileges conferred hereby shall immediately become null and void. Until written notice of any permitted passage of rights under this option shall have been given to and received by the Secretary of
the Company, the Company may, for all purposes, regard the Optionee as the holder of this option. 

1

 

        7.    Method of Exercise.    The rights granted under this Agreement may be exercised by the Optionee, or by the
person or persons to whom the Optionee's rights under this Agreement shall have passed under the provisions of Section 6 hereof, by delivering to the Company in care of its Secretary at the
Company's principal office, written notice of the number of Shares with respect to which the rights are being exercised, accompanied by this Agreement for appropriate endorsement by the Company, such
investment letter as may be required by Section 14 hereof, executed Stockholders Agreement described in Section 8 below, payment of the exercise price, and such other representations and
agreements as may be required by the Administrator. The exercise price may be paid in cash, check, or consideration received by the Company under a broker assisted sale and remittance program
acceptable to the Administrator. 

        8.    Stockholders Agreement.    Notwithstanding any other provision of this Agreement to the contrary, the initial
exercise of this option shall be further conditioned upon the execution and delivery by the Optionee and, if applicable, his/her spouse, of the Stockholders Agreement (in the form attached hereto as
Exhibit A), to the extent not already a party thereto. This provision shall terminate in the event of a Qualified Public Offering. 

        9.    Regulatory Compliance.    The issue and sale of Common Stock pursuant to this Agreement shall be subject to full
compliance with all then applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Common Stock may be listed or traded. 

        10.    Legends.    The certificates evidencing the Common Stock issued upon exercise of this option, if any, shall
bear the following legend, if applicable, at the time of exercise: 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE AND MAY BE OFFERED AND
SOLD ONLY IF REGISTERED PURSUANT TO THE PROVISIONS OF SUCH ACT OR SUCH LAWS OR IF AN EXEMPTION FROM REGISTRATION IS AVAILABLE. 

In
addition, each certificate evidencing the Common Stock issued upon exercise of this option, if any, shall be endorsed with the following legend: 

THE
SHARES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO A STOCKHOLDERS AGREEMENT BETWEEN BRIDGEPOINT EDUCATION, INC., A DELAWARE CORPORATION (THE "COMPANY"), THE HOLDER OF THE SHARES
REPRESENTED BY THIS CERTIFICATE, AND CERTAIN OTHER INVESTORS. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL BUSINESS OFFICE OF THE COMPANY. 

        11.    Modification and Termination.    The rights of the Optionee are subject to modification and termination in
certain events, as provided in the Plan. 

        12.    Withholding Tax.    As a condition to the exercise of this option, the Optionee shall make such arrangements as
the Administrator may require for the satisfaction of any federal, state and local income, and employment tax withholding requirements that may arise in connection with such exercise. The Optionee
shall also make such arrangements as the Administrator may require for the satisfaction of any federal, state and local income, and employment tax withholding requirements that may arise in connection
with the disposition of Shares purchased by exercising this option. The Optionee shall pay to the Company an amount equal to the withholding amount (or the Company may withhold such amount from the
Optionee's salary) in cash or check. At the Administrator's election, the Optionee may pay the withholding amount with Shares (including previously vested Optioned Stock); provided, however, that
payment in Stock shall be limited to the withholding amount calculated using the 

2

 

minimum
statutory withholding rates interpreted in accordance with applicable accounting requirements, or consideration received by the Company under a broker assisted sale and remittance program
acceptable to the Administrator. 

        13.    Holder of Shares.    Neither the Optionee nor the Optionee's legal representative, legatee or distributee shall
be, or be deemed to be, a holder of any Shares subject to this option unless and until such person has been issued a certificate or certificates therefor. No adjustment will be made for dividends or
other rights for which the record date is prior to the date such stock certificate or certificates are so issued. 

        14.    Investment Covenant.    The Optionee represents and agrees that if the Optionee exercises this option in whole
or in part at a time when there is not in effect under the Act, a registration statement relating to the Shares issuable upon exercise hereof and there is not available for delivery a prospectus
meeting the requirements of Section 10(a)(3) of such Act, (i) the Optionee will acquire the Shares upon such exercise for the purpose of investment and not with a view to the
distribution thereof, (ii) if requested by the Company, upon such exercise of this option, the Optionee will furnish to the Company an investment letter in form acceptable to it,
(iii) if requested by the Company, prior to selling or offering for sale any such Shares, the Optionee will furnish the Company with an opinion of counsel satisfactory to it to the effect that
such sale may lawfully be made and will furnish it with such certificates as to factual matters as it may reasonably request, and (iv) certificates representing such shares may be marked with
an appropriate legend describing such conditions precedent to sale or transfer. Any person or persons entitled to exercise this option under the provision of Section 6 hereof shall furnish to
the Company letters, opinions, and certificates to the same effect as would otherwise be required of the Optionee. 

        15.    Nondisclosure.    Optionee acknowledges that the grant and terms of this option are confidential and may not be
disclosed by Optionee to any other person, including other employees of the Company and other participants in the Plan, without the express written consent of the Company's President. Notwithstanding
the foregoing, the Optionee may disclose the grant and terms of this option to the Optionee's family member, financial advisor, and attorney. Any breach of this provision will be deemed to be a
material breach of this Agreement. 

        16.    Governing Law.    This Agreement shall be governed by and interpreted in accordance with the internal laws of
the State of Delaware. 

        17.    Successors.    This Agreement shall inure to the benefit of and be binding upon the parties hereto and their
legal representatives, heirs, and permitted successors and assigns. 

        18.    Plan.    This Agreement is subject to all of the terms and provisions of the Plan, receipt of a copy of which
is hereby acknowledged by the Optionee. The Optionee further acknowledges receipt of a copy of the Stockholders Agreement. The Optionee hereby agrees to accept as binding, conclusive, and final all
decisions and interpretations of the Administrator upon any questions arising under the Plan, this Agreement, and Notice of Stock Option Grant. 

        19.    Rights to Future Employment.    This option does not confer upon the Optionee any right to continue in the
Service of the Company or any Affiliate, nor does it limit the right of the Company to terminate the Service of the Optionee at any time. 

        20.    Market Stand-Off.    In connection with any underwritten public offering by the Company of its
equity securities pursuant to an effective registration statement filed under the Act, including the Company's initial public offering, the Optionee shall not directly or indirectly sell, make any
short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or
transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Agreement without the prior written consent of the Company or its underwriters. Such
restriction (the "Market 

3

 

Stand-Off")
shall be in effect for such period of time following the date of the final prospectus for the offering as may be requested by the Company or such underwriters. In no event,
however, shall such period exceed 180 days. In the event of the declaration of a stock dividend, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or
a similar transaction affecting the Company's outstanding securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction distributed
with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall immediately be subject to the Market Stand-Off. In order
to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares acquired under this Agreement until the end of the applicable
stand-off period. The Company's underwriters shall be beneficiaries of the agreement set forth in this Section. This Section shall not apply to Shares registered in the public offering
under the Act, and the Optionee shall be subject to this Section only if the directors and officers of the Company are subject to similar arrangements. 

        21.    Change in Control.    In the event of a Change in Control prior to the Optionee's Termination Date, the
provisions of Section 6(h) of the Plan shall apply. 

        22.    Entire Agreement.    The Notice of Stock Option Grant, this Agreement, and the Plan constitute the entire
contract between the parties hereto with regard to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and whether express or
implied) which relate to the subject matter hereof. 

4

QuickLinks

Exhibit 10.2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00153-of-00352.parquet"}]]